SlideShare uma empresa Scribd logo
1 de 40
MENINGITIS Dr .PRAVEEN NAGULA
MENINGITIS MENINGITIS
Introduction Infection predominantly involves the subarachnoid space---MENINGITIS. Brain tissue directly involved  is called as  ENCEPHALITIS. Focal bacterial,fungal,parasitic infection involving brain tissue – CEREBRITIS –absence of capsule,ABSCESS presence of capsule.   Nuchal rigidity (STIFF NECK ) – pathognomonic sign of meningeal irritation-resistance to passive flexion. Classical signs of meningeal irritation –KERNIG’S,BRUDZINSKI’S sign.
MENINGES
Meninges
What is ? MENINGISM :the symptoms and signs of meningeal irritation assosciated with acute febrile illness or dehydration without actual infection of the meninges…also called meningismus…PSEUDOMENINGITIS.
KERNIG’S SIGN Patient to be in supine position. Thigh flexed on abdomen. Knee flexed. Attempt to passively extend knee elicit pain when irritation is present.
BRUDZINSKI’S sign Supine position. Passive flexion of neck –spontaneous flexion of hips and knees. Specificity and sensitivity of these tests –UNCERTAIN.
Where they could be absent are?  Immunocompromised Very young or elderly. Severely depressed mental state. False positive – cervical spine disease..
IMPORTANT POINTS.. It is an emergency. Empirical antibiotics to be started. Do CT scan/MRI in case of immunocompromised,recent head trauma,focal neurological deficits  ---LP – but AB not to be delayed. No depressed level of consciousness –think of viral meningitis. Immunocompetent ,consciousness good –can be treated on OP basis. Failure of a patient to improve < 48 hrs – reevaluate the patient,repeat LP ,lab studies and neurological examination.
ACUTE BACTERIAL  MENINGITIS ACUTE BACTERIALMENINGITIS
It is an acute purulent infection within the subarachnoid space.
Most common orgnaisms responsible  for community acquired  bacterial meningitis S.pneumoniae 50% N.meningitidis 25% Group B streptococci - 15% Listeriamonocytogenes 10% Hemophilusinfluenzae  10%
Based on age
TRIAD OF MENINGITIS
ETIOLOGY PNEUMOCOCCAL – from pneumonia,otitis media,alcoholism,diabetes,splenectomy,hypogammaglobulinemia,complement deficiency,head trauma. 20% mortality depsite antimicrobial Rx. N.meningitidis-25% of all cases. Petechiae or purpuric skin rash. Fulminant –death within hours ENTERIC gram negative – chronic debilitating diseases. S.agalacticae -- >50 yrs of age. L.monocytogenes–ingestion of food contaminated.
PATHOGENESIS Nasopharyngeal colonization –asymptomatic carrier. Invasive meningeal disease Depends on bacterial virulence factor ,host immune defense mechanisms Deficiency of complement Highly susceptible
pathogenesis
Much of the pathophysiology is due to direct consequence of chemokines,cytokines.
Clinical features Decreased level of consciousness >75% Nausea,vomiting,photphobia common Classical triad –less sensitivity Only two may be present nearly in all cases. Seizure –initial presentation in 20-40% cases Focal –focal arterial ischemia,cortical venous thrombosis,focal edema GTCS– hyponatremia,anoxia,high dose penicillin. RAISED ICP- >90 % have CSF pressure – 180mmH20 20% -- 400mm H20 Rash of meningococcemia – diffuse,petechial;
DIAGNOSIS CSF analysis Blood cultures CT scan/MRI --- LP  Latex agglutination – S.pneumoniae,N.meningitidis Lumuluslysate –gram negative In case of immunocompetent,no h/o head trauma,no evidence of papilledema –LP without CT scan AB therapy to be started hrs before LP –no change in analysis,or visualization of organisms
CSF analysis
CSF glucose may be zero – CSF/serum glucose corrects for hyperglycemia CSF/s.glucose  < 0.6 CSF/s.glucose < 0.4 – bacterial,fungal,tuberculosis,carcinomatosis 30 min to several hours to reach equilbrium with blood glucose levels –so can start 50 ml of 50 % D. PCR –useful in pretreated pts,gram stain negative MRI >CT for cerebral edema Diffuse meningeal enhancement --gadolinium –increased permeability of BBB.
Differential diagnosis  HSV mimics bacterial meningitis –differentiated by CSF,EEG,neuroimaging. RICKETTESIAL- rash—petechiae—necrosis—gangrene,distal Non infectious – SAH,Chemical meningitis Uveomeningeal syndrome – VogtKoyangiHarada syndrome Subacute –M.tuberculosis,c.noeformans,h.capsulatum
Treatment BEGIN AB < 60 min Empirical treatment –dexamethasone,cefotaxime or ceftriaxone,vancomycin,azithromycin,acyclovir,doxycycline. Post op cases –ceftazidime,cefepime,meropenem,vancomycin Then change according to culture reports
Meningococcal  PENICILLIN G is DOC In case of resistance – Ceftriaxone,cefotaxime Uncomplicated course--7 day course. All close contacts should receive chemoprophylaxis – 2 day regimen of rifampicin 600 mg every 12 hrs * 2days/ciprofloxacin 750 mg od/azithromyxin 500 mg OD/ceftriaxone 250 mg OD Who are close contacts --- nasopharyngeal secretions,kissing,toys,beverages use.
pneumococcal Cephalosporin plus vancomycin If resistance – vancomycin Rifampin can be added synergistic action 2 week course  Repeat LP after 24-36 hrs –sterilization of CSF –if not introventricularvancomycin
Listeria and others Ampicillin for 3 weeks Gentamicin 2mg/kg/d loading – 7.5 mg/kg/d every 8hrs TMP SMX –every 6hrs STAPHYLOCOCCAL –vancomycin Gram negative – 3 weeks of third generation cephalosporin.
Adjunctive therapy Dexamethasone – decreases synthesis of IL1,TNF,stabilises BBB 20 min before AB Rx Inhibits TNF production by macrophages only before activated by endotoxin. Decreases penetration of vancomycin into CSF. 10 mg IV 30 min before AB every 6hrs -4 days.
Raised ICP Elevate head end of bed 30-45 Intubation Hyperventilation PaCo2 – 25-30 mm Hg mannitol
prognosis 20% mortality –pneumococcal 15% - listerias 3-7% h.infleunzae,gram negative.
Who are at risk of poor prognosis Decreased level of consciousness at admission Seziures < 24 hrs of onset Raised ICP  Young age,>50 yrs Mechanical ventilation Delay in treatment <40 mg /dl -glucose >300 mg/dl -protein
sequelae Decreased intellectual function Memory impairement Seizures Hearing loss Gait disturbances
SUMMARY Acute bacterial meningitis is an emergency Triad is seen less commonly Pathognomonic feature is neck rigidity Altered level of consciousness and seziures can be the presenting features. S pneumoniae is the most common organism overall Other organisms based on the age ,and clinical background CSF analysis after CT scan is the rule… PMNs,hypoglycoracchchia,raised proteins and pressure is the hallmark PCR to be done only in negative cases MRI for cerebral edema
Antibiotics for a week in case of uncomplicated meninogcocci,2 weeks in s pneumoniae,3 weeks listeria. All close contacts to be given chemoprophylaxis in case of meningococci with rifampicin 600 mg bid for 2 days. Triad of meningitis is fever,headache,neckstiffness Postoperative cases think of s aurues,gram negative. Ampicillin to be given in case of suspicion of listeria for 3 weeks S. pneumoniae has high mortality of 20%
Antibiotic treatment not to be delayed for the results of investigations Third generation cephalosporins,vancomycin,ampicillindurgs empirically will cover all organisms. Dexamethasone for stabilisingBBB,to be given beofre AB. HSV encephalitis is closest DD 1 week therapy in case of meningococci,2 weeks pneumoniae,3 weeks –listeria Raised ICP –hyperventilate,raise head end,mannitol Sequelae decrease on early management 20% mortality in case of s.pneumoniae Thank you

Mais conteúdo relacionado

Mais procurados (20)

Meningitis
MeningitisMeningitis
Meningitis
 
Peripheral Neuropathy
Peripheral NeuropathyPeripheral Neuropathy
Peripheral Neuropathy
 
Guillain - Barré syndrome
Guillain -  Barré syndrome  Guillain -  Barré syndrome
Guillain - Barré syndrome
 
Neurosyphilis
NeurosyphilisNeurosyphilis
Neurosyphilis
 
IriS
IriSIriS
IriS
 
Acute Rheumatic Fever
Acute Rheumatic FeverAcute Rheumatic Fever
Acute Rheumatic Fever
 
Reactive Arthritis
Reactive  ArthritisReactive  Arthritis
Reactive Arthritis
 
Adem
AdemAdem
Adem
 
Acute flaccid paralysis (AFP)
Acute flaccid paralysis (AFP)Acute flaccid paralysis (AFP)
Acute flaccid paralysis (AFP)
 
Acute bacterial (Pyogenic) meningitis - Dr. S. Srinivasan, Professor of Pedi...
Acute bacterial (Pyogenic)  meningitis - Dr. S. Srinivasan, Professor of Pedi...Acute bacterial (Pyogenic)  meningitis - Dr. S. Srinivasan, Professor of Pedi...
Acute bacterial (Pyogenic) meningitis - Dr. S. Srinivasan, Professor of Pedi...
 
Acute Nephritic Syndromes
Acute Nephritic SyndromesAcute Nephritic Syndromes
Acute Nephritic Syndromes
 
TIA
TIATIA
TIA
 
Viral encephalitis
Viral encephalitisViral encephalitis
Viral encephalitis
 
Ischaemic stroke
Ischaemic stroke Ischaemic stroke
Ischaemic stroke
 
Cerebral Malaria
Cerebral Malaria Cerebral Malaria
Cerebral Malaria
 
Systemic lupus erythematosus (SLE)
Systemic lupus erythematosus (SLE)Systemic lupus erythematosus (SLE)
Systemic lupus erythematosus (SLE)
 
Neurocysticercosis
NeurocysticercosisNeurocysticercosis
Neurocysticercosis
 
Dermatomyositis
DermatomyositisDermatomyositis
Dermatomyositis
 
Ataxia
AtaxiaAtaxia
Ataxia
 
Vasculitis
VasculitisVasculitis
Vasculitis
 

Destaque (16)

TB Meningitis
TB MeningitisTB Meningitis
TB Meningitis
 
Tubercular meningitis
Tubercular meningitisTubercular meningitis
Tubercular meningitis
 
Tuberculous meningitis
Tuberculous meningitisTuberculous meningitis
Tuberculous meningitis
 
Meningococcal meningitis
Meningococcal meningitisMeningococcal meningitis
Meningococcal meningitis
 
Meningitis clase
Meningitis claseMeningitis clase
Meningitis clase
 
Meninges
MeningesMeninges
Meninges
 
Meningococcal meningitis
Meningococcal  meningitisMeningococcal  meningitis
Meningococcal meningitis
 
4 Meningococcal Meningitis
4 Meningococcal Meningitis4 Meningococcal Meningitis
4 Meningococcal Meningitis
 
meningitis
meningitismeningitis
meningitis
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis ppt
Meningitis pptMeningitis ppt
Meningitis ppt
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis
MeningitisMeningitis
Meningitis
 
Meningitis presentation
Meningitis presentationMeningitis presentation
Meningitis presentation
 

Semelhante a Meningitis

MENINGITIS.pptx
MENINGITIS.pptxMENINGITIS.pptx
MENINGITIS.pptxAnusha Are
 
Neurology 10th cns infections
Neurology 10th cns infectionsNeurology 10th cns infections
Neurology 10th cns infectionsRamiAboali
 
CNS INFECTIONS.pdf
CNS INFECTIONS.pdfCNS INFECTIONS.pdf
CNS INFECTIONS.pdfNimonaAAyele
 
22 Purulent Meningitis
22 Purulent Meningitis22 Purulent Meningitis
22 Purulent Meningitisghalan
 
Ayman Kilany, Paediatric CNS infection
Ayman Kilany, Paediatric CNS infectionAyman Kilany, Paediatric CNS infection
Ayman Kilany, Paediatric CNS infectionKIlany Ayman
 
Meningitis (Pediatrics Lecture)
Meningitis (Pediatrics Lecture)Meningitis (Pediatrics Lecture)
Meningitis (Pediatrics Lecture)Karunesh Kumar
 
04 Neurologic
04 Neurologic04 Neurologic
04 NeurologicDeep Deep
 
04 Neurologic
04 Neurologic04 Neurologic
04 NeurologicDeep Deep
 
Meningitis encephalitis slides Dr sarfaraz
Meningitis encephalitis slides Dr sarfarazMeningitis encephalitis slides Dr sarfaraz
Meningitis encephalitis slides Dr sarfarazSarfaraz Ahmad
 
1 Meningitis in children.ppt 44$.ppt
1  Meningitis in children.ppt  44$.ppt1  Meningitis in children.ppt  44$.ppt
1 Meningitis in children.ppt 44$.pptsamirich1
 
Post neonatal menengitis
Post neonatal menengitisPost neonatal menengitis
Post neonatal menengitisIram Ahmed
 
BACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptxBACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptxHajaSovula2
 
MENINGITIS & ENCEPHALITIS - Ayushi.pptx pdf
MENINGITIS & ENCEPHALITIS - Ayushi.pptx pdfMENINGITIS & ENCEPHALITIS - Ayushi.pptx pdf
MENINGITIS & ENCEPHALITIS - Ayushi.pptx pdfAditiShah380128
 
pediatrics Meningitis
pediatrics  Meningitispediatrics  Meningitis
pediatrics MeningitisEric General
 

Semelhante a Meningitis (20)

MENINGITIS.pptx
MENINGITIS.pptxMENINGITIS.pptx
MENINGITIS.pptx
 
Neurology 10th cns infections
Neurology 10th cns infectionsNeurology 10th cns infections
Neurology 10th cns infections
 
CNS INFECTIONS.pdf
CNS INFECTIONS.pdfCNS INFECTIONS.pdf
CNS INFECTIONS.pdf
 
22 Purulent Meningitis
22 Purulent Meningitis22 Purulent Meningitis
22 Purulent Meningitis
 
Ayman Kilany, Paediatric CNS infection
Ayman Kilany, Paediatric CNS infectionAyman Kilany, Paediatric CNS infection
Ayman Kilany, Paediatric CNS infection
 
Meningitis (Pediatrics Lecture)
Meningitis (Pediatrics Lecture)Meningitis (Pediatrics Lecture)
Meningitis (Pediatrics Lecture)
 
Viral meningitis
Viral meningitisViral meningitis
Viral meningitis
 
Meningitis 2010
Meningitis 2010 Meningitis 2010
Meningitis 2010
 
meningitis.pptx
meningitis.pptxmeningitis.pptx
meningitis.pptx
 
04 Neurologic
04 Neurologic04 Neurologic
04 Neurologic
 
04 Neurologic
04 Neurologic04 Neurologic
04 Neurologic
 
Meningitis encephalitis slides Dr sarfaraz
Meningitis encephalitis slides Dr sarfarazMeningitis encephalitis slides Dr sarfaraz
Meningitis encephalitis slides Dr sarfaraz
 
1 Meningitis in children.ppt 44$.ppt
1  Meningitis in children.ppt  44$.ppt1  Meningitis in children.ppt  44$.ppt
1 Meningitis in children.ppt 44$.ppt
 
Meningitis.pptx
Meningitis.pptxMeningitis.pptx
Meningitis.pptx
 
Post neonatal menengitis
Post neonatal menengitisPost neonatal menengitis
Post neonatal menengitis
 
Neisseria Meningitidis
Neisseria MeningitidisNeisseria Meningitidis
Neisseria Meningitidis
 
BACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptxBACTERIAL MENINGITIS present today.pptx
BACTERIAL MENINGITIS present today.pptx
 
CNS Infections
CNS InfectionsCNS Infections
CNS Infections
 
MENINGITIS & ENCEPHALITIS - Ayushi.pptx pdf
MENINGITIS & ENCEPHALITIS - Ayushi.pptx pdfMENINGITIS & ENCEPHALITIS - Ayushi.pptx pdf
MENINGITIS & ENCEPHALITIS - Ayushi.pptx pdf
 
pediatrics Meningitis
pediatrics  Meningitispediatrics  Meningitis
pediatrics Meningitis
 

Mais de Praveen Nagula

historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptxPraveen Nagula
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxPraveen Nagula
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptxPraveen Nagula
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONPraveen Nagula
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxPraveen Nagula
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxPraveen Nagula
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxPraveen Nagula
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not samePraveen Nagula
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIPraveen Nagula
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL Praveen Nagula
 

Mais de Praveen Nagula (20)

BIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptxBIOMARKERS IN HF.pptx
BIOMARKERS IN HF.pptx
 
historical aspects of hypertension.pptx
historical aspects of hypertension.pptxhistorical aspects of hypertension.pptx
historical aspects of hypertension.pptx
 
Management of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptxManagement of AF patients with ACS undergoing PCI.pptx
Management of AF patients with ACS undergoing PCI.pptx
 
ECGs in clinical practice.pptx
ECGs in clinical practice.pptxECGs in clinical practice.pptx
ECGs in clinical practice.pptx
 
PCP IN STEMI.pptx
PCP IN STEMI.pptxPCP IN STEMI.pptx
PCP IN STEMI.pptx
 
HISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSIONHISTORICAL ASPECTS OF HYPERTENSION
HISTORICAL ASPECTS OF HYPERTENSION
 
ATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptxATRIOVENTRICULAR BLOCKS.pptx
ATRIOVENTRICULAR BLOCKS.pptx
 
8.FEMI.pptx
8.FEMI.pptx8.FEMI.pptx
8.FEMI.pptx
 
RHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptxRHYTHM, RATE, AXIS.pptx
RHYTHM, RATE, AXIS.pptx
 
WAVES OF ECG.pptx
WAVES OF ECG.pptxWAVES OF ECG.pptx
WAVES OF ECG.pptx
 
BASICS OF ECG.pptx
BASICS OF ECG.pptxBASICS OF ECG.pptx
BASICS OF ECG.pptx
 
HISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptxHISTORY EVOLUTION OF ECG.pptx
HISTORY EVOLUTION OF ECG.pptx
 
QUIZ IV
QUIZ IVQUIZ IV
QUIZ IV
 
QUIZ .pptx
QUIZ .pptxQUIZ .pptx
QUIZ .pptx
 
QUIZ
QUIZ QUIZ
QUIZ
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Beta blockers all are not same
Beta blockers   all are not sameBeta blockers   all are not same
Beta blockers all are not same
 
INTERESTING ECGS -- PART II
INTERESTING ECGS -- PART IIINTERESTING ECGS -- PART II
INTERESTING ECGS -- PART II
 
how low to go with LDL
how low to go with LDL how low to go with LDL
how low to go with LDL
 
HF update 2021
HF update 2021HF update 2021
HF update 2021
 

Último

ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Disha Kariya
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 

Último (20)

ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..Sports & Fitness Value Added Course FY..
Sports & Fitness Value Added Course FY..
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 

Meningitis

  • 3. Introduction Infection predominantly involves the subarachnoid space---MENINGITIS. Brain tissue directly involved is called as ENCEPHALITIS. Focal bacterial,fungal,parasitic infection involving brain tissue – CEREBRITIS –absence of capsule,ABSCESS presence of capsule. Nuchal rigidity (STIFF NECK ) – pathognomonic sign of meningeal irritation-resistance to passive flexion. Classical signs of meningeal irritation –KERNIG’S,BRUDZINSKI’S sign.
  • 6. What is ? MENINGISM :the symptoms and signs of meningeal irritation assosciated with acute febrile illness or dehydration without actual infection of the meninges…also called meningismus…PSEUDOMENINGITIS.
  • 7. KERNIG’S SIGN Patient to be in supine position. Thigh flexed on abdomen. Knee flexed. Attempt to passively extend knee elicit pain when irritation is present.
  • 8. BRUDZINSKI’S sign Supine position. Passive flexion of neck –spontaneous flexion of hips and knees. Specificity and sensitivity of these tests –UNCERTAIN.
  • 9. Where they could be absent are? Immunocompromised Very young or elderly. Severely depressed mental state. False positive – cervical spine disease..
  • 10. IMPORTANT POINTS.. It is an emergency. Empirical antibiotics to be started. Do CT scan/MRI in case of immunocompromised,recent head trauma,focal neurological deficits ---LP – but AB not to be delayed. No depressed level of consciousness –think of viral meningitis. Immunocompetent ,consciousness good –can be treated on OP basis. Failure of a patient to improve < 48 hrs – reevaluate the patient,repeat LP ,lab studies and neurological examination.
  • 11. ACUTE BACTERIAL MENINGITIS ACUTE BACTERIALMENINGITIS
  • 12. It is an acute purulent infection within the subarachnoid space.
  • 13. Most common orgnaisms responsible for community acquired bacterial meningitis S.pneumoniae 50% N.meningitidis 25% Group B streptococci - 15% Listeriamonocytogenes 10% Hemophilusinfluenzae  10%
  • 16. ETIOLOGY PNEUMOCOCCAL – from pneumonia,otitis media,alcoholism,diabetes,splenectomy,hypogammaglobulinemia,complement deficiency,head trauma. 20% mortality depsite antimicrobial Rx. N.meningitidis-25% of all cases. Petechiae or purpuric skin rash. Fulminant –death within hours ENTERIC gram negative – chronic debilitating diseases. S.agalacticae -- >50 yrs of age. L.monocytogenes–ingestion of food contaminated.
  • 17. PATHOGENESIS Nasopharyngeal colonization –asymptomatic carrier. Invasive meningeal disease Depends on bacterial virulence factor ,host immune defense mechanisms Deficiency of complement Highly susceptible
  • 19. Much of the pathophysiology is due to direct consequence of chemokines,cytokines.
  • 20.
  • 21. Clinical features Decreased level of consciousness >75% Nausea,vomiting,photphobia common Classical triad –less sensitivity Only two may be present nearly in all cases. Seizure –initial presentation in 20-40% cases Focal –focal arterial ischemia,cortical venous thrombosis,focal edema GTCS– hyponatremia,anoxia,high dose penicillin. RAISED ICP- >90 % have CSF pressure – 180mmH20 20% -- 400mm H20 Rash of meningococcemia – diffuse,petechial;
  • 22. DIAGNOSIS CSF analysis Blood cultures CT scan/MRI --- LP Latex agglutination – S.pneumoniae,N.meningitidis Lumuluslysate –gram negative In case of immunocompetent,no h/o head trauma,no evidence of papilledema –LP without CT scan AB therapy to be started hrs before LP –no change in analysis,or visualization of organisms
  • 24. CSF glucose may be zero – CSF/serum glucose corrects for hyperglycemia CSF/s.glucose < 0.6 CSF/s.glucose < 0.4 – bacterial,fungal,tuberculosis,carcinomatosis 30 min to several hours to reach equilbrium with blood glucose levels –so can start 50 ml of 50 % D. PCR –useful in pretreated pts,gram stain negative MRI >CT for cerebral edema Diffuse meningeal enhancement --gadolinium –increased permeability of BBB.
  • 25.
  • 26. Differential diagnosis HSV mimics bacterial meningitis –differentiated by CSF,EEG,neuroimaging. RICKETTESIAL- rash—petechiae—necrosis—gangrene,distal Non infectious – SAH,Chemical meningitis Uveomeningeal syndrome – VogtKoyangiHarada syndrome Subacute –M.tuberculosis,c.noeformans,h.capsulatum
  • 27. Treatment BEGIN AB < 60 min Empirical treatment –dexamethasone,cefotaxime or ceftriaxone,vancomycin,azithromycin,acyclovir,doxycycline. Post op cases –ceftazidime,cefepime,meropenem,vancomycin Then change according to culture reports
  • 28.
  • 29. Meningococcal PENICILLIN G is DOC In case of resistance – Ceftriaxone,cefotaxime Uncomplicated course--7 day course. All close contacts should receive chemoprophylaxis – 2 day regimen of rifampicin 600 mg every 12 hrs * 2days/ciprofloxacin 750 mg od/azithromyxin 500 mg OD/ceftriaxone 250 mg OD Who are close contacts --- nasopharyngeal secretions,kissing,toys,beverages use.
  • 30. pneumococcal Cephalosporin plus vancomycin If resistance – vancomycin Rifampin can be added synergistic action 2 week course Repeat LP after 24-36 hrs –sterilization of CSF –if not introventricularvancomycin
  • 31. Listeria and others Ampicillin for 3 weeks Gentamicin 2mg/kg/d loading – 7.5 mg/kg/d every 8hrs TMP SMX –every 6hrs STAPHYLOCOCCAL –vancomycin Gram negative – 3 weeks of third generation cephalosporin.
  • 32.
  • 33. Adjunctive therapy Dexamethasone – decreases synthesis of IL1,TNF,stabilises BBB 20 min before AB Rx Inhibits TNF production by macrophages only before activated by endotoxin. Decreases penetration of vancomycin into CSF. 10 mg IV 30 min before AB every 6hrs -4 days.
  • 34. Raised ICP Elevate head end of bed 30-45 Intubation Hyperventilation PaCo2 – 25-30 mm Hg mannitol
  • 35. prognosis 20% mortality –pneumococcal 15% - listerias 3-7% h.infleunzae,gram negative.
  • 36. Who are at risk of poor prognosis Decreased level of consciousness at admission Seziures < 24 hrs of onset Raised ICP Young age,>50 yrs Mechanical ventilation Delay in treatment <40 mg /dl -glucose >300 mg/dl -protein
  • 37. sequelae Decreased intellectual function Memory impairement Seizures Hearing loss Gait disturbances
  • 38. SUMMARY Acute bacterial meningitis is an emergency Triad is seen less commonly Pathognomonic feature is neck rigidity Altered level of consciousness and seziures can be the presenting features. S pneumoniae is the most common organism overall Other organisms based on the age ,and clinical background CSF analysis after CT scan is the rule… PMNs,hypoglycoracchchia,raised proteins and pressure is the hallmark PCR to be done only in negative cases MRI for cerebral edema
  • 39. Antibiotics for a week in case of uncomplicated meninogcocci,2 weeks in s pneumoniae,3 weeks listeria. All close contacts to be given chemoprophylaxis in case of meningococci with rifampicin 600 mg bid for 2 days. Triad of meningitis is fever,headache,neckstiffness Postoperative cases think of s aurues,gram negative. Ampicillin to be given in case of suspicion of listeria for 3 weeks S. pneumoniae has high mortality of 20%
  • 40. Antibiotic treatment not to be delayed for the results of investigations Third generation cephalosporins,vancomycin,ampicillindurgs empirically will cover all organisms. Dexamethasone for stabilisingBBB,to be given beofre AB. HSV encephalitis is closest DD 1 week therapy in case of meningococci,2 weeks pneumoniae,3 weeks –listeria Raised ICP –hyperventilate,raise head end,mannitol Sequelae decrease on early management 20% mortality in case of s.pneumoniae Thank you